Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

While the approval is a historic event for the BiTE drug class in solid tumours, the market share opportunity is restricted ...

Tübingen achieves remarkable success and has good chance of maintaining its University of Excellence title – Top research in three areas to be sustained from other sources of support ...

The ASX rose 0.15pc in trade today, driven by Energy sector gains and a US court ruling against Liberation Day tariffs. US ...

The findings provide insight into which patients may have favorable or inferior responses to immunotherapy for small cell ...

The research focuses on immunotherapy. Experts said this treatment could mean fewer surgeries, less chemotherapy, and more hope for patients with some early-stage gastrointestinal cancers.

Christopher Polk/Billboard via Getty The Real Housewives of Beverly Hills alum said that while that means her "body is responding to everything," she does need to live on immunotherapy for the ...

“I'm actually doing great,” Mellencamp told PEOPLE. “I had immunotherapy two days ago and they did another round of scans and they said all my tumors are continuing to shrink, so I'm feeling ...

They have also developed an experimental immunotherapy capable of reversing this process and restoring cellular energy production. The study, recently published in the Journal of Lipid Research ...

HUDSON, Iowa (KWWL) - A second cancer cluster investigation in the town of Hudson is revealing more clues about cases in the community, but limited answers. Retired Hudson teacher Diane Anderson ...